Al Naggar, T. B., Gomez-Serranillos, M. P., Carretero, M. E., and Villar, A. M. Neuropharmacological activity of Nigella sativa L. extracts. J Ethnopharmacol. 2003;88(1):63-68. View abstract.
Al Naqeep, G., Ismail, M., and Allaudin, Z. Regulation of Low-Density Lipoprotein Receptor and 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Gene Expression by Thymoquinone-Rich Fraction and Thymoquinone in HepG2 Cells. J Nutrigenet.Nutrigenomics. 10-30-2009;2(4-5):163-172. View abstract.
al Sheikh, O. A. and Gad el-Rab, M. O. Allergic contact dermatitis: clinical features and profile of sensitizing allergens in Riyadh, Saudi Arabia. Int J Dermatol. 1996;35(7):493-497. View abstract.
Ali, B. H. and Blunden, G. Pharmacological and toxicological properties of Nigella sativa. Phytother.Res. 2003;17(4):299-305. View abstract.
Ali, B. H. The effect of Nigella sativa oil on gentamicin nephrotoxicity in rats. Am.J Chin Med 2004;32(1):49-55. View abstract.
Aljabre, S. H., Randhawa, M. A., Alakloby, O. M., and Alzahrani, A. J. Thymoquinone inhibits germination of dermatophyte arthrospores. Saudi Med J 2009;30(3):443-445. View abstract.
Asgari S and et al. The effects of Nigella sativa on atherosclerosis and its new risk factors in hypercholesterolemic rabbits. Iranian Journal of Diabetes & Lipid Disorders (IRANIAN J DIABETES LIPID DISORD) 2007;6(3):E29.
Awad, E. M. and Binder, B. R. In vitro induction of endothelial cell fibrinolytic alterations by Nigella sativa. Phytomedicine 2005;12(3):194-202. View abstract.
Ayaz, E., Yilmaz, H., Ozbek, H., Tas, Z., and Orunc, O. The effect of Nigella sativa oil against Aspiculuris tetraptera and Hymenolepis nana in naturally infected mice. Saudi Med J 2007;28(11):1654-1657. View abstract.
Azza, M. M. Nadia M. M. Sohair S. Sativa seeds against
Badary, O. A. Thymoquinone attenuates ifosfamide-induced Fanconi syndrome in rats and enhances its antitumor activity in mice. J Ethnopharmacol. 11-1-1999;67(2):135-142. View abstract.
Badary, O. A., Abdel-Naim, A. B., Abdel-Wahab, M. H., and Hamada, F. M. The influence of thymoquinone on doxorubicin-induced hyperlipidemic nephropathy in rats. Toxicology 3-7-2000;143(3):219-226. View abstract.
Badary, O. A., Nagi, M. N., Al Shabanah, O. A., Al Sawaf, H. A., Al Sohaibani, M. O., and Al Bekairi, A. M. Thymoquinone ameliorates the nephrotoxicity induced by cisplatin in rodents and potentiates its antitumor activity. Can J Physiol Pharmacol. 1997;75(12):1356-1361. View abstract.
Bamosa, A. O., Ali, B. A., and al Hawsawi, Z. A. The effect of thymoquinone on blood lipids in rats. Indian J Physiol Pharmacol. 2002;46(2):195-201. View abstract.
Bayrak, O., Bavbek, N., Karatas, O. F., Bayrak, R., Catal, F., Cimentepe, E., Akbas, A., Yildirim, E., Unal, D., and Akcay, A. Nigella sativa protects against ischaemia/reperfusion injury in rat kidneys. Nephrol.Dial.Transplant. 2008;23(7):2206-2212. View abstract.
Benhaddou-Andaloussi A and et al. Antidiabetic activity of Nigella sativa seed extract in cultured pancreatic beta-cells, skeletal muscle cells, and adipocytes. Pharmaceutical Biology (Netherlands) 2010;(46):96-104.
Boskabady MH and et al. Inhibitory effect of Nigella sativa on histamine receptors of isolated guinea pig tracheal chains. Pharmaceutical Biology (Netherlands). 2002;40:596-602.
Boskabady, M. H. and Farhadi, J. The possible prophylactic effect of Nigella sativa seed aqueous extract on respiratory symptoms and pulmonary function tests on chemical war victims: a randomized, double-blind, placebo-controlled trial. J Altern.Complement Med 2008;14(9):1137-1144. View abstract.
Boskabady, M. H., Javan, H., Sajady, M., and Rakhshandeh, H. The possible prophylactic effect of Nigella sativa seed extract in asthmatic patients. Fundam.Clin Pharmacol. 2007;21(5):559-566. View abstract.
Boskabady, M. H., Keyhanmanesh, R., and Saadatloo, M. A. Relaxant effects of different fractions from Nigella sativa L. on guinea pig tracheal chains and its possible mechanism(s). Indian J Exp.Biol. 2008;46(12):805-810. View abstract.
Boskabady, M. H., Mohsenpoor, N., and Takaloo, L. Antiasthmatic effect of Nigella sativa in airways of asthmatic patients. Phytomedicine 2-8-2010; View abstract.
Dahri, A. H., Chandiol, A. M., Rahoo, A. A., and Memon, R. A. Effect of Nigella sativa (kalonji) on serum cholesterol of albino rats. J Ayub.Med Coll.Abbottabad. 2005;17(2):72-74. View abstract.
Dirjomuljono, M., Kristyono, I., Tjandrawinata, R. R., and Nofiarny, D. Symptomatic treatment of acute tonsillo-pharyngitis patients with a combination of Nigella sativa and Phyllanthus niruri extract. Int J Clin Pharmacol.Ther 2008;46(6):295-306. View abstract.
Edris, A. E. Anti-cancer properties of Nigella spp. essential oils and their major constituents, thymoquinone and beta-elemene. Curr.Clin Pharmacol. 2009;4(1):43-46. View abstract.
el Dakhakhny, M., Mady, N. I., and Halim, M. A. Nigella sativa L. oil protects against induced hepatotoxicity and improves serum lipid profile in rats. Arzneimittelforschung. 2000;50(9):832-836. View abstract.
el Dakhakhny, M., Mady, N., Lembert, N., and Ammon, H. P. The hypoglycemic effect of Nigella sativa oil is mediated by extrapancreatic actions. Planta Med 2002;68(5):465-466. View abstract.
El Gazzar, M. A. Thymoquinone suppressses in vitro production of IL-5 and IL-13 by mast cells in response to lipopolysaccharide stimulation. Inflamm.Res 2007;56(8):345-351. View abstract.
El Mahmoudy, A., Shimizu, Y., Shiina, T., Matsuyama, H., Nikami, H., and Takewaki, T. Macrophage-derived cytokine and nitric oxide profiles in type I and type II diabetes mellitus: effect of thymoquinone. Acta Diabetol. 2005;42(1):23-30. View abstract.
El Obeid, A., Al Harbi, S., Al Jomah, N., and Hassib, A. Herbal melanin modulates tumor necrosis factor alpha (TNF-alpha), interleukin 6 (IL-6) and vascular endothelial growth factor (VEGF) production. Phytomedicine. 2006;13(5):324-333. View abstract.
El Saleh, S. C., Al Sagair, O. A., and Al Khalaf, M. I. Thymoquinone and Nigella sativa oil protection against methionine-induced hyperhomocysteinemia in rats. Int J Cardiol. 2004;93(1):19-23. View abstract.
el Tahir, K. E., Ashour, M. M., and al Harbi, M. M. The cardiovascular actions of the volatile oil of the black seed (Nigella sativa) in rats: elucidation of the mechanism of action. Gen.Pharmacol. 1993;24(5):1123-1131. View abstract.
El Wakil, S. S. Evaluation of the in vitro effect of Nigella sativa aqueous extract on Blastocystis hominis isolates. J Egypt Soc.Parasitol. 2007;37(3):801-813. View abstract.
El-Gharieb MA and et al. Potential hepatoprotective effects of vitamin E and Nigella sativa oil on hepatotoxicity induced by chronic exposure to malathion in human and male albino rats. Toxicological & Environmental Chemistry. 2010;92(2):395-412.
Enomoto, S., Asano, R., Iwahori, Y., Narui, T., Okada, Y., Singab, A. N., and Okuyama, T. Hematological studies on black cumin oil from the seeds of Nigella sativa L. Biol.Pharm.Bull 2001;24(3):307-310. View abstract.
Fararh, K. M., Atoji, Y., Shimizu, Y., Shiina, T., Nikami, H., and Takewaki, T. Mechanisms of the hypoglycaemic and immunopotentiating effects of Nigella sativa L. oil in streptozotocin-induced diabetic hamsters. Res Vet.Sci 2004;77(2):123-129. View abstract.
Fararh, K. M., Ibrahim, A. K., and Elsonosy, Y. A. Thymoquinone enhances the activities of enzymes related to energy metabolism in peripheral leukocytes of diabetic rats. Res Vet.Sci 2010;88(3):400-404. View abstract.
Fararh, K. M., Shimizu, Y., Shiina, T., Nikami, H., Ghanem, M. M., and Takewaki, T. Thymoquinone reduces hepatic glucose production in diabetic hamsters. Res Vet.Sci 2005;79(3):219-223. View abstract.
Fouda, A. M., Daba, M. H., Dahab, G. M., and Sharaf El-Din, O. A. Thymoquinone ameliorates renal oxidative damage and proliferative response induced by mercuric chloride in rats. Basic Clin Pharmacol.Toxicol. 2008;103(2):109-118. View abstract.
Gali-Muhtasib, H., Diab-Assaf, M., Boltze, C., Al Hmaira, J., Hartig, R., Roessner, A., and Schneider-Stock, R. Thymoquinone extracted from black seed triggers apoptotic cell death in human colorectal cancer cells via a p53-dependent mechanism. Int J Oncol. 2004;25(4):857-866. View abstract.
Gali-Muhtasib, H., Roessner, A., and Schneider-Stock, R. Thymoquinone: a promising anti-cancer drug from natural sources. Int J Biochem Cell Biol. 2006;38(8):1249-1253. View abstract.
Ghannadi, A., Hajhashemi, V., and Jafarabadi, H. An investigation of the analgesic and anti-inflammatory effects of Nigella sativa seed polyphenols. J Med Food 2005;8(4):488-493. View abstract.
Hansen, J. T., Benghuzzi, H., Tucci, M., and Cason, Z. The role of black seed in the proliferation and biochemical marker levels of Hep-2 cells. Biomed.Sci.Instrum. 2003;39:371-376. View abstract.
Hawsawi, Z. A., Ali, B. A., and Bamosa, A. O. Effect of Nigella sativa (Black Seed) and thymoquinone on blood glucose in albino rats. Ann.Saudi Med 2001;21(3-4):242-244. View abstract.
Hosseinzadeh, H. and Parvardeh, S. Anticonvulsant effects of thymoquinone, the major constituent of Nigella sativa seeds, in mice. Phytomedicine 2004;11(1):56-64. View abstract.
Hosseinzadeh, H., Parvardeh, S., Nassiri-Asl, M., and Mansouri, M. T. Intracerebroventricular administration of thymoquinone, the major constituent of Nigella sativa seeds, suppresses epileptic seizures in rats. Med Sci Monit. 2005;11(4):BR106-BR110. View abstract.
Ilhan, A., Gurel, A., Armutcu, F., Kamisli, S., and Iraz, M. Antiepileptogenic and antioxidant effects of Nigella sativa oil against pentylenetetrazol-induced kindling in mice. Neuropharmacology 2005;49(4):456-464. View abstract.
Islam, S. K., Ahsan, M., Hassan, C. M., and Malek, M. A. Antifungal activities of the oils of Nigella sativa seeds. Pak.J Pharm.Sci 1989;2(1):25-28. View abstract.
Islam, S. N., Begum, P., Ahsan, T., Huque, S., and Ahsan, M. Immunosuppressive and cytotoxic properties of Nigella sativa. Phytother.Res. 2004;18(5):395-398. View abstract.
Jadayil, S. A., Tukan, S. K., and Takruri, H. R. Bioavailability of iron from four different local food plants in Jordan. Plant Foods Hum.Nutr. 1999;54(4):285-294. View abstract.
Kalus, U., Pruss, A., Bystron, J., Jurecka, M., Smekalova, A., Lichius, J. J., and Kiesewetter, H. Effect of Nigella sativa (black seed) on subjective feeling in patients with allergic diseases. Phytother.Res. 2003;17(10):1209-1214. View abstract.
Kamal EH and et al. Some cardiovascular effects of the dethymoquinonated Nigella sativa volatile oil and its major components alpha-pinene and p-cymene in rats. Saudi Pharmaceutical Journal (Saudi Arabia). 2003;11:104-110.
Kanter, M. Effects of Nigella sativa and its major constituent, thymoquinone on sciatic nerves in experimental diabetic neuropathy. Neurochem.Res 2008;33(1):87-96. View abstract.
Kanter, M. Effects of Nigella sativa seed extract on ameliorating lung tissue damage in rats after experimental pulmonary aspirations. Acta Histochem. 2009;111(5):393-403. View abstract.
Kanter, M. Protective effects of thymoquinone on streptozotocin-induced diabetic nephropathy. J Mol.Histol. 2009;40(2):107-115. View abstract.
Kanter, M., Coskun, O., and Uysal, H. The antioxidative and antihistaminic effect of Nigella sativa and its major constituent, thymoquinone on ethanol-induced gastric mucosal damage. Arch Toxicol. 2006;80(4):217-224. View abstract.
Kanter, M., Coskun, O., Korkmaz, A., and Oter, S. Effects of Nigella sativa on oxidative stress and beta-cell damage in streptozotocin-induced diabetic rats. Anat.Rec.A Discov.Mol.Cell Evol.Biol. 2004;279(1):685-691. View abstract.
Kanter, M., Demir, H., Karakaya, C., and Ozbek, H. Gastroprotective activity of Nigella sativa L oil and its constituent, thymoquinone against acute alcohol-induced gastric mucosal injury in rats. World J Gastroenterol. 11-14-2005;11(42):6662-6666. View abstract.
Kanter, M., Meral, I., Yener, Z., Ozbek, H., and Demir, H. Partial regeneration/proliferation of the beta-cells in the islets of Langerhans by Nigella sativa L. in streptozotocin-induced diabetic rats. Tohoku J Exp.Med 2003;201(4):213-219. View abstract.
Keyhanmanesh, R., Boskabady, M. H., Eslamizadeh, M. J., Khamneh, S., and Ebrahimi, M. A. The effect of thymoquinone, the main constituent of Nigella sativa on tracheal responsiveness and white blood cell count in lung lavage of sensitized guinea pigs. Planta Med 2010;76(3):218-222. View abstract.
Kocyigit, Y., Atamer, Y., and Uysal, E. The effect of dietary supplementation of Nigella sativa L. on serum lipid profile in rats. Saudi Med J 2009;30(7):893-896. View abstract.
Kumara, S. S. and Huat, B. T. Extraction, isolation and characterisation of antitumor principle, alpha-hederin, from the seeds of Nigella sativa. Planta Med 2001;67(1):29-32. View abstract.
Landa, P., Kokoska, L., Pribylova, M., Vanek, T., and Marsik, P. In vitro anti-inflammatory activity of carvacrol: Inhibitory effect on COX-2 catalyzed prostaglandin E(2) biosynthesis. Arch Pharm.Res 2009;32(1):75-78. View abstract.
Landa, P., Marsik, P., Havlik, J., Kloucek, P., Vanek, T., and Kokoska, L. Evaluation of antimicrobial and anti-inflammatory activities of seed extracts from six Nigella species. J Med Food 2009;12(2):408-415. View abstract.
Le, P. M., Benhaddou-Andaloussi, A., Elimadi, A., Settaf, A., Cherrah, Y., and Haddad, P. S. The petroleum ether extract of Nigella sativa exerts lipid-lowering and insulin-sensitizing actions in the rat. J Ethnopharmacol. 2004;94(2-3):251-259. View abstract.
Mansour, M. and Tornhamre, S. Inhibition of 5-lipoxygenase and leukotriene C4 synthase in human blood cells by thymoquinone. J Enzyme Inhib.Med Chem. 2004;19(5):431-436. View abstract.
Marsik, P., Kokoska, L., Landa, P., Nepovim, A., Soudek, P., and Vanek, T. In vitro inhibitory effects of thymol and quinones of Nigella sativa seeds on cyclooxygenase-1- and -2-catalyzed prostaglandin E2 biosyntheses. Planta Med 2005;71(8):739-742. View abstract.
Massadeh, A. M., Al Safi, S. A., Momani, I. F., Al Mahmoud, M., and Alkofahi, A. S. Analysis of cadmium and lead in mice organs: effect of Nigella sativa L. (Black Cumin) on the distribution and immunosuppressive effect of cadmium-lead mixture in mice. Biol.Trace Elem.Res 2007;115(2):157-167. View abstract.
Abdullah, A. Z., Strafford, S. M., Brookes, S. J., and Duggal, M. S. The effect of copper on demineralization of dental enamel. J Dent Res 2006;85(11):1011-1015. View abstract.
Araya, M., McGoldrick, M. C., Klevay, L. M., Strain, J. J., Robson, P., Nielsen, F., Olivares, M., Pizarro, F., Johnson, L. A., and Poirier, K. A. Determination of an acute no-observed-adverse-effect level (NOAEL) for copper in water. Regul.Toxicol.Pharmacol. 2001;34(2):137-145. View abstract.
Araya, M., Olivares, M., Pizarro, F., Llanos, A., Figueroa, G., and Uauy, R. Community-based randomized double-blind study of gastrointestinal effects and copper exposure in drinking water. Environ.Health Perspect. 2004;112(10):1068-1073. View abstract.
Ashkenazi, A., Levin, S., Djaldetti, M., Fishel, E., and Benvenisti, D. The syndrome of neonatal copper deficiency. Pediatrics 1973;52(4):525-533. View abstract.
August, D., Janghorbani, M., and Young, V. R. Determination of zinc and copper absorption at three dietary Zn-Cu ratios by using stable isotope methods in young adult and elderly subjects. Am J Clin Nutr 1989;50(6):1457-1463. View abstract.
Baker, A., Harvey, L., Majask-Newman, G., Fairweather-Tait, S., Flynn, A., and Cashman, K. Effect of dietary copper intakes on biochemical markers of bone metabolism in healthy adult males. Eur.J.Clin.Nutr. 1999;53(5):408-412. View abstract.
Baker, A., Turley, E., Bonham, M. P., O'Connor, J. M., Strain, J. J., Flynn, A., and Cashman, K. D. No effect of copper supplementation on biochemical markers of bone metabolism in healthy adults. Br.J.Nutr. 1999;82(4):283-290. View abstract.
BAKWIN, R. M. Ceruloplasmin activity and copper levels in the serum of children with schizophrenia. J Am Med Womens Assoc 1961;16:522-523. View abstract.
BAKWIN, R. M., MOSBACH, E. H., and BAKWIN, H. Concentration of copper in serum of children with schizophrenia. Pediatrics 1961;27:642-644. View abstract.
Bonham, M., O'Connor, J. M., McAnena, L. B., Walsh, P. M., Downes, C. S., Hannigan, B. M., and Strain, J. J. Zinc supplementation has no effect on lipoprotein metabolism, hemostasis, and putative indices of copper status in healthy men. Biol.Trace Elem.Res. 2003;93(1-3):75-86. View abstract.
Bowman, M. B. and Lewis, M. S. The copper hypothesis of schizophrenia: a review. Neurosci.Biobehav.Rev 1982;6(3):321-328. View abstract.
Brown, N. A., Bron, A. J., Harding, J. J., and Dewar, H. M. Nutrition supplements and the eye. Eye 1998;12 ( Pt 1):127-133. View abstract.
Bugel, S., Harper, A., Rock, E., O'Connor, J. M., Bonham, M. P., and Strain, J. J. Effect of copper supplementation on indices of copper status and certain CVD risk markers in young healthy women. Br.J Nutr 2005;94(2):231-236. View abstract.
Burdeinyi, A. F. [Levels of copper and zinc in the blood of patients with various types of schizophrenia]. Zh.Nevropatol.Psikhiatr.Im S.S.Korsakova 1967;67(7):1041-1043. View abstract.
Bureau, I., Lewis, C. G., and Fields, M. Effect of hepatic iron on hypercholesterolemia and hypertriacylglycerolemia in copper-deficient fructose-fed rats. Nutrition 1998;14(4):366-371. View abstract.
Cashman, K. D., Baker, A., Ginty, F., Flynn, A., Strain, J. J., Bonham, M. P., O'Connor, J. M., Bugel, S., and Sandstrom, B. No effect of copper supplementation on biochemical markers of bone metabolism in healthy young adult females despite apparently improved copper status. Eur.J.Clin.Nutr. 2001;55(7):525-531. View abstract.
Castillo-Duran, C., Fisberg, M., Valenzuela, A., Egana, J. I., and Uauy, R. Controlled trial of copper supplementation during the recovery from marasmus. Am.J.Clin.Nutr. 1983;37(6):898-903. View abstract.
Chitre, V. S. and Punekar, B. D. Changes in serum copper and PPD-oxidase in different diseases. II. Comparative studies in Wilson's disease schizophrenia and Parkinsonism. Indian J Med Res 1970;58(5):563-573. View abstract.
Christodoulou, J., Danks, D. M., Sarkar, B., Baerlocher, K. E., Casey, R., Horn, N., Tumer, Z., and Clarke, J. T. Early treatment of Menkes disease with parenteral copper-histidine: long-term follow-up of four treated patients. Am J Med Genet. 3-5-1998;76(2):154-164. View abstract.
Chugh, T. D., Dhingra, R. K., Gulati, R. C., and Bathla, J. C. Copper metabolism in schizophrenia. Indian J Med Res 1973;61(8):1147-1152. View abstract.
Czeizel, A. E. and Dudas, I. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl.J Med 12-24-1992;327(26):1832-1835. View abstract.
da Silveira, S. V., Canato, C., de Jorge, F. B., and Delascio, D. [Copper, iron, magnesium and sulfur in the serum of pregnant women with sideroblastic anemia before, during, and after parenteral iron infusion therapy]. Matern.Infanc.(Sao Paulo) 1967;26(3):269-273. View abstract.
DOGAN, S., KELER, M., and PERSIC, N. [Copper in blood in schizophrenia; a problem of pathophysiology of schizophrenia.]. Acta Med Iugosl. 1955;9(1):60-70. View abstract.
Fiske, D. N., McCoy, H. E., III, and Kitchens, C. S. Zinc-induced sideroblastic anemia: report of a case, review of the literature, and description of the hematologic syndrome. Am J Hematol. 1994;46(2):147-150. View abstract.
Freycon, F. and Pouyau, G. [Rare nutritional deficiency anemia: deficiency of copper and vitamin E]. Sem.Hop. 2-17-1983;59(7):488-493. View abstract.
George, D. H. and Casey, R. E. Menkes disease after copper histidine replacement therapy: case report. Pediatr Dev.Pathol. 2001;4(3):281-288. View abstract.
Gillin, J. C., Carpenter, W. T., Hambidge, K. M., Wyatt, R. J., and Henkin, R. I. Zinc and copper in patients with schizophrenia. Encephale 1982;8(3):435-444. View abstract.
Gorter, R. W., Butorac, M., and Cobian, E. P. Examination of the cutaneous absorption of copper after the use of copper-containing ointments. Am J Ther 2004;11(6):453-458. View abstract.
Gregg, X. T., Reddy, V., and Prchal, J. T. Copper deficiency masquerading as myelodysplastic syndrome. Blood 8-15-2002;100(4):1493-1495. View abstract.
Harvey, L. J., Majsak-Newman, G., Dainty, J. R., Lewis, D. J., Langford, N. J., Crews, H. M., and Fairweather-Tait, S. J. Adaptive responses in men fed low- and high-copper diets. Br J Nutr 2003;90(1):161-168. View abstract.
Henry, N. L., Dunn, R., Merjaver, S., Pan, Q., Pienta, K. J., Brewer, G., and Smith, D. C. Phase II trial of copper depletion with tetrathiomolybdate as an antiangiogenesis strategy in patients with hormone-refractory prostate cancer. Oncology 2006;71(3-4):168-175. View abstract.
Herran, A., Garcia-Unzueta, M. T., Fernandez-Gonzalez, M. D., Vazquez-Barquero, J. L., Alvarez, C., and Amado, J. A. Higher levels of serum copper in schizophrenic patients treated with depot neuroleptics. Psychiatry Res 4-24-2000;94(1):51-58. View abstract.
Humphries, W. R., Phillippo, M., Young, B. W., and Bremner, I. The influence of dietary iron and molybdenum on copper metabolism in calves. Br.J.Nutr. 1983;49(1):77-86. View abstract.
Institute of Medicine ed. Food and Nutrition Board. Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc (2000). National Academy Press;2000.
Irving, J. A., Mattman, A., Lockitch, G., Farrell, K., and Wadsworth, L. D. Element of caution: a case of reversible cytopenias associated with excessive zinc supplementation. CMAJ. 7-22-2003;169(2):129-131. View abstract.
Jendryczko, A., Drozdz, M., and Magner, K. Antilupus activity of copper (II). Exp Pathol. 1985;28(3):187-189. View abstract.
Kappel, L. C., Ingraham, R. H., Morgan, E. B., and Babcock, D. K. Plasma copper concentration and packed cell volume and their relationships to fertility and milk production in Holstein cows. Am.J.Vet.Res. 1984;45(2):346-350. View abstract.
Kelley, D. S., Daudu, P. A., Taylor, P. C., Mackey, B. E., and Turnlund, J. R. Effects of low-copper diets on human immune response. Am.J.Clin.Nutr. 1995;62(2):412-416. View abstract.
Kessler, H., Bayer, T. A., Bach, D., Schneider-Axmann, T., Supprian, T., Herrmann, W., Haber, M., Multhaup, G., Falkai, P., and Pajonk, F. G. Intake of copper has no effect on cognition in patients with mild Alzheimer's disease: a pilot phase 2 clinical trial. J Neural Transm. 2008;115(8):1181-1187. View abstract.
Kimura, A., Yoshino, H., and Yuasa, T. [A case of cerebellar degeneration with schizophrenia-like psychosis, severe iron deficiency, hypoceruloplasminemia and abnormal electroretinography: a new syndrome?]. Rinsho Shinkeigaku 2001;41(8):507-511. View abstract.
Kirodian, B. G., Gogtay, N. J., Udani, V. P., and Kshirsagar, N. A. Treatment of Menkes disease with parenteral copper histidine. Indian Pediatr 2002;39(2):183-185. View abstract.
Klevay, L. M. Interactions of copper and zinc in cardiovascular disease. Ann.N.Y.Acad.Sci. 1980;355:140-151. View abstract.
Klevay, L. M. The influence of copper and zinc on the occurrence of ischemic heart disease. J.Environ.Pathol.Toxicol. 1980;4(2-3):281-287. View abstract.
Klevay, L. M., Reck, S. J., Jacob, R. A., Logan, G. M., Jr., Munoz, J. M., and Sandstead, H. H. The human requirement for copper. I. Healthy men fed conventional, American diets. Am.J.Clin.Nutr. 1980;33(1):45-50. View abstract.
KOEGLER, R. R., COLBERT, E. G., and EIDUSON, S. Wanted: a biochemical test for schizophrenia. Calif.Med 1961;94:26-29. View abstract.
KOLAKOWSKA, T., SZAJBEL, W., and MURAWSKI, K. [Serum ceruloplasmin and copper in schizophrenia.]. Neurol.Neurochir.Psychiatr.Pol. 1960;10:691-696. View abstract.
Kreuder, J., Otten, A., Fuder, H., Tumer, Z., Tonnesen, T., Horn, N., and Dralle, D. Clinical and biochemical consequences of copper-histidine therapy in Menkes disease. Eur J Pediatr 1993;152(10):828-832. View abstract.
Kumar, A. and Jazieh, A. R. Case report of sideroblastic anemia caused by ingestion of coins. Am J Hematol. 2001;66(2):126-129. View abstract.
Lei, K. Y. Oxidation, excretion, and tissue distribution of [26-14C] cholesterol in copper-deficient rats. J.Nutr. 1978;108(2):232-237. View abstract.
MAAS, J. W., GLESER, G. C., and GOTTSCHALK, L. A. Schizophrenia, anxiety, and biochemical factors. The rate of oxidation of N, N-dimethyl-p-phenylenediamine by plasma and levels of serum copper and plasma ascorbic acid. Arch Gen.Psychiatry 1961;4:109-118. View abstract.
May, A. and Fitzsimons, E. Sideroblastic anaemia. Baillieres Clin Haematol. 1994;7(4):851-879. View abstract.
Miller, T. R., Wagner, J. D., Baack, B. R., and Eisbach, K. J. Effects of topical copper tripeptide complex on CO2 laser-resurfaced skin. Arch Facial.Plast.Surg 2006;8(4):252-259. View abstract.
Munakata, M., Sakamoto, O., Kitamura, T., Ishitobi, M., Yokoyama, H., Haginoya, K., Togashi, N., Tamura, H., Higano, S., Takahashi, S., Ohura, T., Kobayashi, Y., Onuma, A., and Iinuma, K. The effects of copper-histidine therapy on brain metabolism in a patient with Menkes disease: a proton magnetic resonance spectroscopic study. Brain Dev. 2005;27(4):297-300. View abstract.
MUNCH-PETERSEN, S. On serum copper in patients with schizophrenia. Acta Psychiatr.Neurol. 1951;25(4):423-427. View abstract.
O'Donohue, J., Reid, M., Varghese, A., Portmann, B., and Williams, R. A case of adult chronic copper self-intoxication resulting in cirrhosis. Eur J Med Res 6-28-1999;4(6):252. View abstract.
Olatunbosun, D. A., Akindele, M. O., Adadevoh, B. K., and Asuni, T. Serum copper in schizophrenia in Nigerians. Br J Psychiatry 1975;127:119-121. View abstract.
OZEK, M. [Research on copper metabolism in several forms of schizophrenia.]. Arch Psychiatr.Nervenkr.Z Gesamte Neurol.Psychiatr. 1957;195(4):408-423. View abstract.
Patel, A., Dibley, M. J., Mamtani, M., Badhoniya, N., and Kulkarni, H. Zinc and copper supplementation in acute diarrhea in children: a double-blind randomized controlled trial. BMC.Med 2009;7:22. View abstract.
Patterson, W. P., Winkelmann, M., and Perry, M. C. Zinc-induced copper deficiency: megamineral sideroblastic anemia. Ann Intern Med 1985;103(3):385-386. View abstract.
Perry, A. R., Pagliuca, A., Fitzsimons, E. J., Mufti, G. J., and Williams, R. Acquired sideroblastic anaemia induced by a copper-chelating agent. Int J Hematol. 1996;64(1):69-72. View abstract.
Porea, T. J., Belmont, J. W., and Mahoney, D. H., Jr. Zinc-induced anemia and neutropenia in an adolescent. J Pediatr 2000;136(5):688-690. View abstract.
Puzynski, S. [Studies of the significance of disturbances in the metabolism of copper, ceruloplasmin and ascorbic acid in the pathogenesis of schizophrenia]. Rocz.Akad.Med Im Juliana Marchlewskiego Bialymst. 1969;14:99-162. View abstract.
Rahman, B., Rahman, M. A., and Hassan, Z. Copper and caeruloplasmin in schizophrenia. Biochem Soc Trans 1976;4(6):1138-1139. View abstract.
Ramadurai, J., Shapiro, C., Kozloff, M., and Telfer, M. Zinc abuse and sideroblastic anemia. Am J Hematol. 1993;42(2):227-228. View abstract.
Rhee, Y. S., Hermann, J. R., Burnham, K., Arquitt, A. B., and Stoecker, B. J. The effects of chromium and copper supplementation on mitogen-stimulated T cell proliferation in hypercholesterolaemic postmenopausal women. Clin.Exp.Immunol. 2002;127(3):463-469. View abstract.
Rivera Bandres J. [On some recently well-known anemias]. Rev Esp.Enferm.Apar.Dig 1966;25(8):942-958. View abstract.
Rodriguez, E. and Diaz, C. Iron, copper and zinc levels in urine: relationship to various individual factors. J Trace Elem.Med Biol 1995;9(4):200-209. View abstract.
Sarkar, B., Lingertat-Walsh, K., and Clarke, J. T. Copper-histidine therapy for Menkes disease. J Pediatr 1993;123(5):828-830. View abstract.
Shackel, N. A., Day, R. O., Kellett, B., and Brooks, P. M. Copper-salicylate gel for pain relief in osteoarthritis: a randomised controlled trial. Med J Aust. 8-4-1997;167(3):134-136. View abstract.
Sheela, S. R., Latha, M., Liu, P., Lem, K., and Kaler, S. G. Copper-replacement treatment for symptomatic Menkes disease: ethical considerations. Clin Genet. 2005;68(3):278-283. View abstract.
Sheth, S. and Brittenham, G. M. Genetic disorders affecting proteins of iron metabolism: clinical implications. Annu Rev Med 2000;51:443-464. View abstract.
Shore, D., Potkin, S. G., Weinberger, D. R., Torrey, E. F., Henkin, R. I., Agarwal, R. P., Gillin, J. C., and Wyatt, R. J. CSF copper concentrations in chronic schizophrenia. Am J Psychiatry 1983;140(6):754-757. View abstract.
Silverstone, B. Z., Landau, L., Berson, D., and Sternbuch, J. Zinc and copper metabolism in patients with senile macular degeneration. Ann.Ophthalmol. 1985;17(7):419-422. View abstract.
Simon, S. R., Branda, R. F., Tindle, B. F., and Burns, S. L. Copper deficiency and sideroblastic anemia associated with zinc ingestion. Am J Hematol. 1988;28(3):181-183. View abstract.
Skalski, M. [Disorders of copper metabolism]. Wiad.Lek. 8-15-1986;39(16):1120-1123. View abstract.
Sorenson, J. R. Evaluation of copper complexes as potential anti-arthritic drugs. J Pharm Pharmacol 1977;29(7):450-452. View abstract.
Strain, J. J. A reassessment of diet and osteoporosis--possible role for copper. Med Hypotheses 1988;27(4):333-338. View abstract.
Tashiro, A., Satodate, R., and Segawa, I. Histological changes in cardiac hemochromatosis improved by an iron-chelating agent. A biopsy case. Acta Pathol Jpn. 1990;40(4):288-292. View abstract.
Tokdemir, M., Polat, S. A., Acik, Y., Gursu, F., Cikim, G., and Deniz, O. Blood zinc and copper concentrations in criminal and noncriminal schizophrenic men. Arch Androl 2003;49(5):365-368. View abstract.
Turnlund, J. R., Keyes, W. R., Kim, S. K., and Domek, J. M. Long-term high copper intake: effects on copper absorption, retention, and homeostasis in men. Am J Clin Nutr 2005;81(4):822-828. View abstract.
Tyrer, S. P., Delves, H. T., and Weller, M. P. CSF copper in schizophrenia. Am J Psychiatry 1979;136(7):937-939. View abstract.
Van Wouwe, J. P. and Veldhuizen, M. Growth characteristics in laboratory animals fed zinc-deficient, copper-deficient, of histidine-supplemented diets. Biol.Trace Elem.Res. 1996;55(1-2):71-77. View abstract.
Waler, S. M. and Rolla, G. Comparison between plaque inhibiting effect of chlorhexidine and aqueous solutions of copper- and silver-ions. Scand J Dent.Res 1982;90(2):131-133. View abstract.
Walker, W. R. and Keats, D. M. An investigation of the therapeutic value of the 'copper bracelet'-dermal assimilation of copper in arthritic/rheumatoid conditions. Agents Actions 1976;6(4):454-459. View abstract.
Weis, S., Haybaeck, J., Dulay, J. R., and Llenos, I. C. Expression of cellular prion protein (PrP(c)) in schizophrenia, bipolar disorder, and depression. J Neural Transm. 2008;115(5):761-771. View abstract.
Willis, M. S., Monaghan, S. A., Miller, M. L., McKenna, R. W., Perkins, W. D., Levinson, B. S., Bhushan, V., and Kroft, S. H. Zinc-induced copper deficiency: a report of three cases initially recognized on bone marrow examination. Am J Clin Pathol 2005;123(1):125-131. View abstract.
Wolf, T. L., Kotun, J., and Meador-Woodruff, J. H. Plasma copper, iron, ceruloplasmin and ferroxidase activity in schizophrenia. Schizophr.Res 2006;86(1-3):167-171. View abstract.
Yamazaki, H., Fujieda, M., Togashi, M., Saito, T., Preti, G., Cashman, J. R., and Kamataki, T. Effects of the dietary supplements, activated charcoal and copper chlorophyllin, on urinary excretion of trimethylamine in Japanese trimethylaminuria patients. Life Sci. 4-16-2004;74(22):2739-2747. View abstract.
Yanik, M., Kocyigit, A., Tutkun, H., Vural, H., and Herken, H. Plasma manganese, selenium, zinc, copper, and iron concentrations in patients with schizophrenia. Biol Trace Elem.Res 2004;98(2):109-117. View abstract.
Arendsen LP, Thakar R, Bassett P, Sultan AH. The impact of copper impregnated wound dressings on surgical site infection following caesarean section: a double blind randomised controlled study. Eur J Obstet Gynecol Reprod Biol. 2020;251:83-88. View abstract.
Arendsen LP, Vig S, Thakar R, Sultan AH. Impact of copper compression stockings on venous insufficiency and lipodermatosclerosis: A randomized controlled trial. Phlebology. 2019;34(4):224-230. View abstract.
Babic Z, Tariba B, Kovacic J, Pizent A, Varnai VM, Macan J. Relevance of serum copper elevation induced by oral contraceptives: a meta-analysis. Contraception. 2013 Jun;87(6):790-800. View abstract.
Baum MK, Javier JJ, Mantero-Atienza E, et al. Zidovudine-associated adverse reactions in a longitudinal study of asymptomatic HIV-1-infected homosexual males. J Acquir Immune Defic Syndr 1991;4:1218-26. View abstract.
Brewer GJ, Dick RD, Johnson VD, et al. Treatment of Wilson's disease with zinc: XV long-term follow-up studies. J Lab Clin Med 1998;132:264-78. View abstract.
Broun ER, Greist A, Tricot G, Hoffman R. Excessive zinc ingestion. A reversible cause of sideroblastic anemia and bone marrow depression. JAMA 1990;264:1441-3. View abstract.
Campbell IA, Elmes PC. Ethambutol and the eye: zinc and copper (letter). Lancet 1975;2:711. View abstract.
Campbell WW, Anderson RA. Effects of aerobic exercise and training on the trace minerals chromium, zinc and copper. Sports Med 1987 4:9-18. View abstract.
Cantilena LR, Klaassen CD. The effect of chelating agents on the excretion of endogenous metals. Toxicol Appl Pharmacol 1982;63:344-50. View abstract.
Castillo-Duran, C., Vial, P., and Uauy, R. Oral copper supplementation: effect on copper and zinc balance during acute gastroenteritis in infants. Am.J.Clin.Nutr. 1990;51(6):1088-1092. 2349923. View abstract.
Chung KJ, Chin YM, Wong MS, Sanmugam A, Singaravel S, Nah SA. Effectiveness of table salt versus copper sulphate in treating umbilical granuloma: A pilot randomized controlled trial. J Pediatr Surg 2022;57(2):261-265. View abstract.
Clarkson PM, Haymes EM. Trace mineral requirements for athletes. Int J Sport Nutr 1994;4:104-19. View abstract.
Clarkson PM. Minerals: exercise performance and supplementation in athletes. J Sports Sci 1991;9:91-116. View abstract.
Cole A, May PM, Williams DR. Metal binding by pharmaceuticals. Part 1. Copper(II) and zinc(II) interactions following ethambutol administration. Agents Actions 1981;11:296-305. View abstract.
Duffy EM, Meenagh GK, McMillan SA, et al. The clinical effect of dietary supplementation with omega-3 fish oils and/or copper in systemic lupus erythematosus. J Rheumatol 2004;31:1551-6. View abstract.
Finley EB, Cerklewski FL. Influence of ascorbic acid supplementation on copper status in young adult men. Am J Clin Nutr 1983;37:553-6. View abstract.
Food and Nutrition Board, Institute of Medicine. Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc. Washington, DC: National Academy Press, 2002. Available at: www.nap.edu/books/0309072794/html/.
Gallentine A. Third-degree burn on the neuropathic lower extremity in a patient with diabetes while wearing a copper-containing compression sock: a case report. Wound Manag Prev 2021;67(12):26-29. View abstract.
Gossel TA, Bricker JD. Principles of Clinical Toxicology. New York, NY:Raven Press, 1994.
Hardman JG, Limbird LL, Molinoff PB, eds. Goodman and Gillman's The Pharmacological Basis of Therapeutics, 9th ed. New York, NY: McGraw-Hill, 1996.
Kozak SF, Inderlied CB, Hsu HY, et al. The role of copper on ethambutol's antimicrobial action and implications for ethambutol-induced optic neuropathy. Diag Microbiol Infect Dis 1998;30:83-7. View abstract.
Lai H, Lai S, Shor-Posner G, et al. Plasma zinc, copper, copper:zinc ratio, and survival in a cohort of HIV-1-infected homosexual men. J Acquir Immune Defic Syndr Human Retrovirol 2001;27:56-62. View abstract.
LiverTox: Clinical and Research Information on Drug-Induced Liver Injury. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012-. Chelating Agents. Accessed on August 25, 2021. Available at: https://www.ncbi.nlm.nih.gov/books/NBK548531/
Murry JJ, Healy MD. Drug-mineral interactions: a new responsibility for the hospital dietician. J Am Diet Assoc 1991;91:66-73. View abstract.
Nechifor M, Vaideanu C, Palamaru I, et al. The influence of some antipsychotics on erythrocyte magnesium and plasma magnesium, calcium, copper and zinc in patients with paranoid schizophrenia. J Am Coll Nutr 2004;23:549S-51S. View abstract.
Olivares M, Figueroa C, Pizarro F. Acute copper and ascorbic acid supplementation inhibits non-heme iron absorption in humans. Biol Trace Elem Res 2016;172(2):315-9. View abstract.
Olivares M, Pizarro F, López de Romaña D, Ruz M. Acute copper supplementation does not inhibit non-heme iron bioavailability in humans. Biol Trace Elem Res. 2010 Aug;136(2):180-6. View abstract.
Ostwal V, Ramaswamy A, Bhargava P, et al. A pro-oxidant combination of resveratrol and copper reduces chemotherapy-related non-haematological toxicities in advanced gastric cancer: results of a prospective open label phase II single-arm study (RESCU III study). Med Oncol 2022;40(1):17. View abstract.
Patel AB, Dibley MJ, Mamtani M, Badhoniya N, Kulkarni H. Therapeutic zinc and copper supplementation in acute diarrhea does not influence short-term morbidity and growth: double-blind randomized controlled trial. Pediatr Infect Dis J 2013;32(1):91-3. View abstract.
Pecanac M, Janjic Z, Komarcevic A, Pajic M, Dobanovacki D, Miskovic SS. Burns treatment in ancient times. Med Pregl. 2013 May-Jun;66(5-6):263-7. View abstract.
Pedro EM, da Rosa Franchi Santos LF, Scavuzzi BM, et al. Trace elements associated with systemic lupus erythematosus and insulin resistance. Biol Trace Elem Res. 2019;191(1):34-44. View abstract.
Qui Q, Zhang F, Zhu W, Wu J, Liang M. Copper in diabetes mellitus: a meta-analysis and systematic review of plasma and serum studies. Biol Trace Elem Res 2017;177(1):53-63. View abstract.
Rubin MA, Miller JP, Ryan AS, et al. Acute and chronic resistive exercise increase urinary chromium excretion in men as measured with an enriched chromium stable isotope. J Nutr 1998;128:73-78. View abstract.
Salim, S, Farquharson, J, Arneil, G, et al. Dietary copper intake in artificially fed infants. Arch Dis.Child 1986;61(11):1068-1075. 3789787. View abstract.
Sandstead HH. Requirements and toxicity of essential trace elements, illustrated by zinc and copper. Am J Clin Nutr 1995;61:621S-4S. View abstract.
Segal S, Kaminski S. Drug-nutrient interactions. American Druggist 1996 Jul;42-8.
Shalita AR, Falcon R, Olansky A, Iannotta P, Akhavan A, Day D, Janiga A, Singri P, Kallal JE. Inflammatory acne management with a novel prescription dietary supplement. J Drugs Dermatol. 2012;11(12):1428-33. View abstract.
Shankar JA, Kaur A, Tyagi L, Selvam S, Hans R, Pannu AK. Severe copper sulphate poisoning: A case rescued with plasmapheresis. Trop Doct 2023;53(2):327-328. View abstract.
Squitti R, Simonelli I, Ventriglia M, et al. Meta-analysis of serum non-ceruloplasmin copper in Alzheimer's disease. J Alzheimers Dis 2014;38(4):809-22. View abstract.
Strause L, Saltman P, Smith KT, et al. Spinal bone loss in postmenopausal women supplemented with calcium and trace minerals. J Nutr 1994;124:1060-4. View abstract.
Valberg, LS, Flanagan, PR, Chamberlain, MJ. Effects of iron, tin, and copper on zinc absorption in humans. Am J Clin Nutr 1984;40(3):536-541. View abstract.
Walker-Smith PK, Keith DJ, Kennedy CT, Sansom JE. Allergic contact dermatitis caused by copper. Contact Dermatitis 2016;75(3):186-7. View abstract.
Weight LM, Noakes TD, Labadarios D, et al. Vitamin and mineral status of trained athletes including the effects of supplementation. Am J Clin Nutr 1988;47:186-91. View abstract.
Werlenius K, Kinhult S, Solheim TS, et al. Effect of Disulfiram and Copper Plus Chemotherapy vs Chemotherapy Alone on Survival in Patients With Recurrent Glioblastoma: A Randomized Clinical Trial. JAMA Netw Open 2023;6(3):e234149. View abstract.
Select a condition to view a list of vitamins
CONDITIONS OF USE AND IMPORTANT INFORMATION: This information is meant to supplement, not replace advice from your doctor or healthcare provider and is not meant to cover all possible uses, precautions, interactions or adverse effects. This information may not fit your specific health circumstances. Never delay or disregard seeking professional medical advice from your doctor or other qualified health care provider because of something you have read on WebMD. You should always speak with your doctor or health care professional before you start, stop, or change any prescribed part of your health care plan or treatment and to determine what course of therapy is right for you.
This copyrighted material is licensed from Therapeutic Research Center, LLC. Information from this source is evidence-based and objective, and without commercial influence. For professional medical information on natural medicines, see Natural Medicines Comprehensive Database Professional Version.
Licensed from Therapeutic Research Center, LLC
Copyright © 1995-2024 by Therapeutic Research Center, LLC. All Rights Reserved.